Islam Khalid

Islam Khalid is listed in filings as Director at Gain Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 25, 2025, including purchase activity. Recent filings connect the profile to Gain Therapeutics, Inc. (GANX) and Fennec Pharmaceuticals Inc. (FENC). The current snapshot covers public activity from Jun 26, 2024 to Jun 25, 2025. Reported amounts are shown as $19.4K to $26.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.